Celekoksib (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Celekoksib" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

30nih.gov

4^th place

8^th place

23doi.org

2^nd place

5^th place

3web.archive.org

1^st place

2^nd place

3archive.org

6^th place

9^th place

2fda.gov

447^th place

409^th place

2cbz.si

low place

607^th place

2drugs.com

399^th place

169^th place

2worldcat.org

5^th place

10^th place

1termania.net

low place

34^th place

1drugbank.ca

4,294^th place

2,993^rd place

1europa.eu

68^th place

28^th place

1bmj.com

1,226^th place

862^nd place

1ahajournals.org

3,608^th place

1,222^nd place

ahajournals.org

circ.ahajournals.org

Antman EM, in sod. (Marec 2007). »Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association« (PDF). Circulation. 115 (12): 1634–1642. doi:10.1161/circulationaha.106.181424. PMID 17325246.

archive.org

Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM (2007). »Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials«. Rheumatology. 46 (1): 135–40. doi:10.1093/rheumatology/kel195. PMID 16777855.
Chen LC, Ashcroft DM (2006). »Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials«. J Clin Pharm Ther. 31 (6): 565–76. doi:10.1111/j.1365-2710.2006.00774.x. PMID 17176361.
Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ (28. oktober 2008). »ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents«. Journal of the American College of Cardiology. 52 (18): 1502–1517. doi:10.1016/j.jacc.2008.08.002. PMID 19017521.

bmj.com

ebmh.bmj.com

Fan X, Song X (Februar 2013). »Review: non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics« (PDF). Evidence-Based Mental Health. 16 (1): 10. doi:10.1136/eb-2012-100865. PMID 23093694.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BSEZNAMUCINKNAZIV%5D=_celekoksib*)&SearchOrder=4&SearchMax=301, vpogled: 25. 1. 2017.
http://www.cbz.si/cbz/bazazdr2.nsf/o/94E11718B1137C29C12579EC002007C7/$File/s-017514.pdf Arhivirano 2017-02-02 na Wayback Machine. Povzetek glavih značilnosti zdravila Celebrex, datum zadnje revizije zdravila: 26. 9. 2016

doi.org

McCormack, PL (december 2011). »Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis«. Drugs. 71 (18): 2457–89. doi:10.2165/11208240-000000000-00000. PMID 22141388.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (31. avgust 2013). »Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials«. Lancet. 382 (9894): 769–79. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Derry, Sheena; Moore, R. Andrew (22. oktober 2013). »Single dose oral celecoxib for acute postoperative pain in adults«. The Cochrane Database of Systematic Reviews. 10: CD004233. doi:10.1002/14651858.CD004233.pub4. ISSN 1469-493X. PMID 24150982.
Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM (2007). »Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials«. Rheumatology. 46 (1): 135–40. doi:10.1093/rheumatology/kel195. PMID 16777855.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (september 2007). »OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence«. Osteoarthr. Cartil. 15 (9): 981–1000. doi:10.1016/j.joca.2007.06.014. PMID 17719803.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
da Costa, BR; Reichenbach, S; Keller, N; Nartey, L; Wandel, S; Jüni, P; Trelle, S (21. maj 2016). »Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis«. Lancet (London, England). 387 (10033): 2093–2105. doi:10.1016/s0140-6736(16)30002-2. PMID 26997557.
Fan X, Song X (Februar 2013). »Review: non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics« (PDF). Evidence-Based Mental Health. 16 (1): 10. doi:10.1136/eb-2012-100865. PMID 23093694.
Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ (april 2013). »Anti-inflammatory treatment in schizophrenia«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 146–53. doi:10.1016/j.pnpbp.2012.11.008. PMID 23178230.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Na KS, Lee KJ, Lee JS, Cho YS, Jung HY (Januar 2014). »Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48: 79–85. doi:10.1016/j.pnpbp.2013.09.006. PMID 24056287.
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (Januar 2014). »Inflamed moods: A review of the interactions between inflammation and mood disorders«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 53C: 23–34. doi:10.1016/j.pnpbp.2014.01.013. PMID 24468642.
Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, Oliveira J, Le Guen E, Marlinge E, Tamouza R, Leboyer M (Marec 2014). »Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review«. Acta Psychiatrica Scandinavica. 129 (3): 163–79. doi:10.1111/acps.12211. PMID 24215721.
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005). »Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention«. The New England Journal of Medicine. Adenoma Prevention with Celecoxib (APC) Study Investigators. 352 (11): 1071–1080. doi:10.1056/NEJMoa050405. PMID 15713944.
Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL (2005). »Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction«. Ann. Intern. Med. 142 (3): 157–64. doi:10.7326/0003-4819-142-3-200502010-00005. PMID 15684203.
Antman EM, in sod. (Marec 2007). »Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association« (PDF). Circulation. 115 (12): 1634–1642. doi:10.1161/circulationaha.106.181424. PMID 17325246.
Mukherjee D, Nissen SE, Topol EJ (2001). »Risk of cardiovascular events associated with selective COX-2 inhibitors«. JAMA. 286 (8): 954–9. doi:10.1001/jama.286.8.954. PMID 11509060.
Chen LC, Ashcroft DM (2006). »Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials«. J Clin Pharm Ther. 31 (6): 565–76. doi:10.1111/j.1365-2710.2006.00774.x. PMID 17176361.
Nissen, Steven E.; Yeomans, Neville D.; Solomon, Daniel H.; Lüscher, Thomas F.; Libby, Peter; Husni, M. Elaine; Graham, David Y.; Borer, Jeffrey S.; Wisniewski, Lisa M.; Wolski, Katherine E.; Wang, Qiuqing; Menon, Venu; Ruschitzka, Frank; Gaffney, Michael; Beckerman, Bruce; Berger, Manuela F.; Bao, Weihang; Lincoff, A. Michael (2016). »Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis«. New England Journal of Medicine. 375 (26): 2519–2529. doi:10.1056/NEJMoa1611593. ISSN 0028-4793. PMID 27959716.
Mathew ST, Devi SG, Prasanth VV, Vinod B (2011). »Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review«. ISRN pharmacology. 2011: 480291. doi:10.5402/2011/480291. PMC 3197256. PMID 22084715.
Shi S, Klotz U (Marec 2008). »Clinical use and pharmacological properties of selective COX-2 inhibitors«. European journal of clinical pharmacology. 64 (3): 233–52. doi:10.1007/s00228-007-0400-7. PMID 17999057.
Conaghan PG (Junij 2012). »A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity«. Rheumatology international. 32 (6): 1491–502. doi:10.1007/s00296-011-2263-6. PMC 3364420. PMID 22193214.
Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ (28. oktober 2008). »ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents«. Journal of the American College of Cardiology. 52 (18): 1502–1517. doi:10.1016/j.jacc.2008.08.002. PMID 19017521.
Half E, Arber N (Februar 2009). »Colon cancer: preventive agents and the present status of chemoprevention«. Expert opinion on pharmacotherapy. 10 (2): 211–9. doi:10.1517/14656560802560153. PMID 19236194.
Assefnia S, Dakshanamurthy S, Guidry Auvil JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown ML, Shapiro L, Brenner M, Haigh D, Byers SW (Marec 2014). »Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies«. Oncotarget. 5 (6): 1458–1474. doi:10.18632/oncotarget.1538. PMC 4039224. PMID 24681547.

drugbank.ca

https://www.drugbank.ca/drugs/DB00482, vpogled: 25. 1. 2017.

drugs.com

»Celexoxib«. The American Society of Health-System Pharmacists. Pridobljeno 2. januarja 2015.
»Celecoxib«. The American Society of Health-System Pharmacists. Pridobljeno 21. aprila 2014.

europa.eu

ema.europa.eu

http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2011/04/WC500104950.pdf Arhivirano 2016-12-19 na Wayback Machine., vpogled: 25. 1. 2017.

fda.gov

»FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes«. Food and Drug Administration. 9. julij 2015. Pridobljeno 27. decembra 2015.
Jenkins JK, Seligman PJ (6. april 2005). »Analysis and recommendations for Agency action regarding nonsteroidal anti-inflammatory drugs and cardiovascular risk [decision memorandum]« (PDF). FDA Center for Drug Evaluation and Research. Arhivirano iz prvotnega spletišča (PDF) dne 9. septembra 2005. Pridobljeno 25. januarja 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

McCormack, PL (december 2011). »Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis«. Drugs. 71 (18): 2457–89. doi:10.2165/11208240-000000000-00000. PMID 22141388.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (31. avgust 2013). »Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials«. Lancet. 382 (9894): 769–79. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Derry, Sheena; Moore, R. Andrew (22. oktober 2013). »Single dose oral celecoxib for acute postoperative pain in adults«. The Cochrane Database of Systematic Reviews. 10: CD004233. doi:10.1002/14651858.CD004233.pub4. ISSN 1469-493X. PMID 24150982.
Yelland MJ, Nikles CJ, McNairn N, Del Mar CB, Schluter PJ, Brown RM (2007). »Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials«. Rheumatology. 46 (1): 135–40. doi:10.1093/rheumatology/kel195. PMID 16777855.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (september 2007). »OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence«. Osteoarthr. Cartil. 15 (9): 981–1000. doi:10.1016/j.joca.2007.06.014. PMID 17719803.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Flood J (Marec 2010). »The role of acetaminophen in the treatment of osteoarthritis«. The American journal of managed care. 16 Suppl Management: S48–54. PMID 20297877.
da Costa, BR; Reichenbach, S; Keller, N; Nartey, L; Wandel, S; Jüni, P; Trelle, S (21. maj 2016). »Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis«. Lancet (London, England). 387 (10033): 2093–2105. doi:10.1016/s0140-6736(16)30002-2. PMID 26997557.
Fan X, Song X (Februar 2013). »Review: non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics« (PDF). Evidence-Based Mental Health. 16 (1): 10. doi:10.1136/eb-2012-100865. PMID 23093694.
Müller N, Myint AM, Krause D, Weidinger E, Schwarz MJ (april 2013). »Anti-inflammatory treatment in schizophrenia«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 42: 146–53. doi:10.1016/j.pnpbp.2012.11.008. PMID 23178230.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Na KS, Lee KJ, Lee JS, Cho YS, Jung HY (Januar 2014). »Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 48: 79–85. doi:10.1016/j.pnpbp.2013.09.006. PMID 24056287.
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS (Januar 2014). »Inflamed moods: A review of the interactions between inflammation and mood disorders«. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 53C: 23–34. doi:10.1016/j.pnpbp.2014.01.013. PMID 24468642.
Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, Oliveira J, Le Guen E, Marlinge E, Tamouza R, Leboyer M (Marec 2014). »Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review«. Acta Psychiatrica Scandinavica. 129 (3): 163–79. doi:10.1111/acps.12211. PMID 24215721.
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005). »Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention«. The New England Journal of Medicine. Adenoma Prevention with Celecoxib (APC) Study Investigators. 352 (11): 1071–1080. doi:10.1056/NEJMoa050405. PMID 15713944.
Kimmel SE, Berlin JA, Reilly M, Jaskowiak J, Kishel L, Chittams J, Strom BL (2005). »Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction«. Ann. Intern. Med. 142 (3): 157–64. doi:10.7326/0003-4819-142-3-200502010-00005. PMID 15684203.
Antman EM, in sod. (Marec 2007). »Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association« (PDF). Circulation. 115 (12): 1634–1642. doi:10.1161/circulationaha.106.181424. PMID 17325246.
Mukherjee D, Nissen SE, Topol EJ (2001). »Risk of cardiovascular events associated with selective COX-2 inhibitors«. JAMA. 286 (8): 954–9. doi:10.1001/jama.286.8.954. PMID 11509060.
Chen LC, Ashcroft DM (2006). »Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials«. J Clin Pharm Ther. 31 (6): 565–76. doi:10.1111/j.1365-2710.2006.00774.x. PMID 17176361.
Nissen, Steven E.; Yeomans, Neville D.; Solomon, Daniel H.; Lüscher, Thomas F.; Libby, Peter; Husni, M. Elaine; Graham, David Y.; Borer, Jeffrey S.; Wisniewski, Lisa M.; Wolski, Katherine E.; Wang, Qiuqing; Menon, Venu; Ruschitzka, Frank; Gaffney, Michael; Beckerman, Bruce; Berger, Manuela F.; Bao, Weihang; Lincoff, A. Michael (2016). »Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis«. New England Journal of Medicine. 375 (26): 2519–2529. doi:10.1056/NEJMoa1611593. ISSN 0028-4793. PMID 27959716.
Mathew ST, Devi SG, Prasanth VV, Vinod B (2011). »Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review«. ISRN pharmacology. 2011: 480291. doi:10.5402/2011/480291. PMC 3197256. PMID 22084715.
Shi S, Klotz U (Marec 2008). »Clinical use and pharmacological properties of selective COX-2 inhibitors«. European journal of clinical pharmacology. 64 (3): 233–52. doi:10.1007/s00228-007-0400-7. PMID 17999057.
Conaghan PG (Junij 2012). »A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity«. Rheumatology international. 32 (6): 1491–502. doi:10.1007/s00296-011-2263-6. PMC 3364420. PMID 22193214.
Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ (28. oktober 2008). »ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents«. Journal of the American College of Cardiology. 52 (18): 1502–1517. doi:10.1016/j.jacc.2008.08.002. PMID 19017521.
Half E, Arber N (Februar 2009). »Colon cancer: preventive agents and the present status of chemoprevention«. Expert opinion on pharmacotherapy. 10 (2): 211–9. doi:10.1517/14656560802560153. PMID 19236194.
Assefnia S, Dakshanamurthy S, Guidry Auvil JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown ML, Shapiro L, Brenner M, Haigh D, Byers SW (Marec 2014). »Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies«. Oncotarget. 5 (6): 1458–1474. doi:10.18632/oncotarget.1538. PMC 4039224. PMID 24681547.

ncbi.nlm.nih.gov

Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (31. avgust 2013). »Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials«. Lancet. 382 (9894): 769–79. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
Derry, Sheena; Moore, R. Andrew (22. oktober 2013). »Single dose oral celecoxib for acute postoperative pain in adults«. The Cochrane Database of Systematic Reviews. 10: CD004233. doi:10.1002/14651858.CD004233.pub4. ISSN 1469-493X. PMID 24150982.
Mathew ST, Devi SG, Prasanth VV, Vinod B (2011). »Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review«. ISRN pharmacology. 2011: 480291. doi:10.5402/2011/480291. PMC 3197256. PMID 22084715.
Conaghan PG (Junij 2012). »A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity«. Rheumatology international. 32 (6): 1491–502. doi:10.1007/s00296-011-2263-6. PMC 3364420. PMID 22193214.
Assefnia S, Dakshanamurthy S, Guidry Auvil JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown ML, Shapiro L, Brenner M, Haigh D, Byers SW (Marec 2014). »Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies«. Oncotarget. 5 (6): 1458–1474. doi:10.18632/oncotarget.1538. PMC 4039224. PMID 24681547.

dailymed.nlm.nih.gov

»Drug Label«.

termania.net

http://www.termania.net/slovarji/slovenski-medicinski-slovar/5509406/celekoksib?query=celekoksib&SearchIn=All, Slovenski medicinski e-slovar, vpogled: 25. 1. 2017.

web.archive.org

http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2011/04/WC500104950.pdf Arhivirano 2016-12-19 na Wayback Machine., vpogled: 25. 1. 2017.
http://www.cbz.si/cbz/bazazdr2.nsf/o/94E11718B1137C29C12579EC002007C7/$File/s-017514.pdf Arhivirano 2017-02-02 na Wayback Machine. Povzetek glavih značilnosti zdravila Celebrex, datum zadnje revizije zdravila: 26. 9. 2016
Jenkins JK, Seligman PJ (6. april 2005). »Analysis and recommendations for Agency action regarding nonsteroidal anti-inflammatory drugs and cardiovascular risk [decision memorandum]« (PDF). FDA Center for Drug Evaluation and Research. Arhivirano iz prvotnega spletišča (PDF) dne 9. septembra 2005. Pridobljeno 25. januarja 2017.

worldcat.org

Derry, Sheena; Moore, R. Andrew (22. oktober 2013). »Single dose oral celecoxib for acute postoperative pain in adults«. The Cochrane Database of Systematic Reviews. 10: CD004233. doi:10.1002/14651858.CD004233.pub4. ISSN 1469-493X. PMID 24150982.
Nissen, Steven E.; Yeomans, Neville D.; Solomon, Daniel H.; Lüscher, Thomas F.; Libby, Peter; Husni, M. Elaine; Graham, David Y.; Borer, Jeffrey S.; Wisniewski, Lisa M.; Wolski, Katherine E.; Wang, Qiuqing; Menon, Venu; Ruschitzka, Frank; Gaffney, Michael; Beckerman, Bruce; Berger, Manuela F.; Bao, Weihang; Lincoff, A. Michael (2016). »Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis«. New England Journal of Medicine. 375 (26): 2519–2529. doi:10.1056/NEJMoa1611593. ISSN 0028-4793. PMID 27959716.